The US is doing more in the COVID-19 space than anywhere in the world due to the strength of its innovative ecosystem, says Michelle McMurry-Heath, president & CEO of life sciences... Read more »
Driven by 20 years in the military, the founder of Theradaptive hopes his firm’s regenerative “paint” technology platform can transform bone repair, spinal fusion, and sports medicine.
The firm, spun out... Read more »
Johnson & Johnson’s global head of external innovation says there needs to be a shift in how healthcare research is funded to focus on early detection and curing rather than managing... Read more »
Healthcare investment firm LSP has raised what it says is the largest ever European fund focused on life sciences ventures.
The Amsterdam, Netherlands-headquartered firm aimed to bring in $450 million in... Read more »
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped Falcon Therapeutics CEO Susan Nichols’ annual roundup.
In what has... Read more »
Page 1 of 2